Trial Profile
Planned adaptive design phase II trial of P53-gene-therapy-MultiVir in patients with colorectal liver metastases.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2014
Price :
$35
*
At a glance
- Drugs P53 gene therapy - MultiVir (Primary) ; Cetuximab; Fluorouracil; Folinic acid; Irinotecan
- Indications Cancer metastases; Colorectal cancer
- Focus Registrational; Therapeutic Use
- 03 Mar 2014 New trial record